Jill Denning is currently the VP of Clinical Development at Kinevant Sciences, a position held since 2023. With a robust background in clinical research, Jill previously served as VP at Enzyvant and VP of Clinical Research at Altavant Sciences. Their extensive experience includes roles as Director of Clinical Research at Gilead Sciences and Pharmasset, as well as Director of Clinical Pharmacology at Glaxosmithkline and Aai Pharma. Jill began their career as a Clinical Research Associate at Quintiles Pharma Inc from 1997 to 1999. They are currently pursuing a Master of Arts in Exercise Physiology at the University of North Carolina at Chapel Hill.
This person is not in any teams
This person is not in any offices